About
Live Bacterial Treatments
Areas of Focus
Categories
Small Molecule PharmaceuticalMicrobiomeBoston & New England
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
60
By Phase
PHASE1: 2
By Status
COMPLETED: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
Today
Hover over trial bars to see details
Recent Trials
NCT05084261Lead Sponsor
An Investigation of Oral BT051 in Subjects With Moderately to Severely Active Ulcerative Colitis (UC)
PHASE1Completed
24 participants
Started: Nov 30, 2021 · Completed: Nov 30, 2022
NCT04891965Lead Sponsor
A Study of ART24 in Subjects Recently Cured of a Clostridioides Difficile Infection (CDI)
PHASE1Completed
36 participants
Started: Feb 27, 2020 · Completed: Oct 13, 2022
Locations (1)
Headquarters
Concord, MA, United States
Map
Loading map...